Northwestern Mutual Wealth Management CO Nektar Therapeutics Transaction History

Northwestern Mutual Wealth Management CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.53 - $1.03 $431 - $839	-815 Reduced 80.3%	200 $0
Q4 2022 Feb 21, 2023	SELL	$2.03 - $4.28 $355 - $749	-175 Reduced 14.71%	1,015 $2,000
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $6,387 - $10,799	-2,101 Reduced 63.84%	1,190 $4,000
Q1 2022 May 09, 2022	BUY	$4.16 - $13.72 $2,704 - $8,918	650 Added 24.61%	3,291 $17,000
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $21,251 - $30,633	1,626 Added 160.2%	2,641 $47,000
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $16,560 - $25,460	-1,000 Reduced 49.63%	1,015 $20,000
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $16,860 - $23,440	1,000 Added 98.52%	2,015 $47,000
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $17,163 - $36,814	1,015 New	1,015 $18,000
Q4 2017 Jan 31, 2018	SELL	$23.02 - $60.5 $4,604 - $12,100	-200 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$17.79 - $24.0 $480 - $648	27 Added 15.61%	200 $5,000
Q2 2017 Aug 10, 2017	BUY	N/A	173	173 $3,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.